American International Group’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-68,744
Closed -$2.22M 2195
2024
Q1
$2.22M Sell
68,744
-2,750
-4% -$81.5K 0.01% 973
2023
Q4
$2.05M Buy
71,494
+20,881
+41% +$502K 0.01% 991
2023
Q3
$1.4M Buy
50,613
+1,798
+4% +$53.3K 0.01% 1075
2023
Q2
$1.31M Buy
48,815
+6,841
+16% +$168K 0.01% 1121
2023
Q1
$909K Buy
41,974
+6,312
+18% +$155K 0.01% 1269
2022
Q4
$849K Buy
35,662
+311
+0.9% +$6.61K 0.01% 1287
2022
Q3
$697K Buy
35,351
+5,851
+20% +$129K 0.01% 1379
2022
Q2
$575K Buy
29,500
+11
+0% +$214 ﹤0.01% 1521
2022
Q1
$752K Sell
29,489
-2,076
-7% -$45.2K ﹤0.01% 1494
2021
Q4
$794K Sell
31,565
-944
-3% -$26.6K ﹤0.01% 1552
2021
Q3
$894K Sell
32,509
-772
-2% -$22.5K ﹤0.01% 1500
2021
Q2
$1.06K Buy
33,281
+8,386
+34% +$293K ﹤0.01% 1483
2021
Q1
$1.14K Buy
24,895
+2,469
+11% +$111K ﹤0.01% 1386
2020
Q4
$888 Sell
22,426
-643
-3% -$25.4K ﹤0.01% 1454
2020
Q3
$803K Buy
23,069
+14,106
+157% +$391K ﹤0.01% 1354
2020
Q2
$283K Buy
8,963
+602
+7% +$18.9K ﹤0.01% 1922
2020
Q1
$183K Buy
+8,361
New +$231K ﹤0.01% 1953

Other funds holding RVMD

American International Group's RVMD Position: Q2 2024 in Review

American International Group sold out of Revolution Medicines (RVMD) in Q2 2024, closing a stake of 68,744 shares — an estimated $2.22M sold.

American International Group first reported a position in RVMD in Q1 2020 and held it in 17 quarters. The position peaked at $2.22M in Q1 2024. 223 funds tracked by Wall St. Rank hold RVMD as of Q2 2024.

  • American International Group reported no remaining Revolution Medicines position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 68,744 Revolution Medicines shares in Q2 2024, an estimated $2.22M.
  • American International Group first reported a position in Revolution Medicines in Q1 2020 and held it in 17 quarters.
  • American International Group's Revolution Medicines position peaked at $2.22M in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.